Big Pharma Split Stock Analysis
| PRM Stock | CAD 13.15 0.09 0.69% |
Big Pharma Split is fairly valued with Real Value of 12.73 and Hype Value of 13.03. The main objective of Big Pharma stock analysis is to determine its intrinsic value, which is an estimate of what Big Pharma Split is worth, separate from its market price. There are two main types of Big Pharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Big Pharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Big Pharma's stock to identify patterns and trends that may indicate its future price movements.
The Big Pharma stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Big Pharma is usually not traded on Civic Holiday, Labour Day, Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day, Canada Day. Big Stock trading window is adjusted to America/Toronto timezone.
Big |
Big Stock Analysis Notes
The company has price-to-book ratio of 0.93. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Big Pharma Split last dividend was issued on the 28th of June 2024. Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada. BIG PHARMA operates under Asset Management classification in Canada and is traded on Toronto Stock Exchange. To find out more about Big Pharma Split contact the company at 416-649-4541 or learn more at https://www.harvestportfolios.com/closed-end-funds.Big Pharma Split Investment Alerts
| Big Pharma Split generated a negative expected return over the last 90 days | |
| Big Pharma Split has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 311.76 K. Net Loss for the year was (645.35 K) with profit before overhead, payroll, taxes, and interest of 320.82 K. |
Big Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 14.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Big Pharma's market, we take the total number of its shares issued and multiply it by Big Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Big Profitablity
Big Pharma's profitability indicators refer to fundamental financial ratios that showcase Big Pharma's ability to generate income relative to its revenue or operating costs. If, let's say, Big Pharma is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Big Pharma's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Big Pharma's profitability requires more research than a typical breakdown of Big Pharma's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (2.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.51 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.51. Technical Drivers
As of the 22nd of January, Big Pharma shows the mean deviation of 0.7288, and Risk Adjusted Performance of (0.06). In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Big Pharma, as well as the relationship between them.Big Pharma Split Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Big Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Big Pharma Split. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Big Pharma Outstanding Bonds
Big Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Big Pharma Split uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Big bonds can be classified according to their maturity, which is the date when Big Pharma Split has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Big Pharma Predictive Daily Indicators
Big Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Big Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 13.15 | |||
| Day Typical Price | 13.15 | |||
| Price Action Indicator | 0.045 | |||
| Period Momentum Indicator | 0.09 |
Big Pharma Forecast Models
Big Pharma's time-series forecasting models are one of many Big Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Big Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Big Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Big Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Big shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Big Pharma. By using and applying Big Stock analysis, traders can create a robust methodology for identifying Big entry and exit points for their positions.
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada. BIG PHARMA operates under Asset Management classification in Canada and is traded on Toronto Stock Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Big Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Other Information on Investing in Big Stock
Big Pharma financial ratios help investors to determine whether Big Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Big with respect to the benefits of owning Big Pharma security.